Biology • Year 12 • Module 8 • Lesson 15

Benefits of Epidemiological Studies

Lock in the vocabulary of epidemiological benefit, the benefit chain, the three risk measures and the screening criteria, the foundations for evaluating benefits using examples at HSC level.

Build · Recall & Vocab

1. Complete the benefit chain

An epidemiological study delivers its full benefit only when every link in the chain holds. Write the missing labels into boxes A–H using the lesson Key Terms and the card "From association to action". 8 marks

The four links of the benefit chain A B C D the study finds a pattern or risk factor someone with power turns it into a campaign or policy the target population can actually reach it new data check whether exposure or disease moved Putting a number on it E F G H compares disease rates in exposed and unexposed the actual probability for one person share of cases removing the exposure would prevent what the benefit shrinks to if any link breaks
BoxYour label
A
B
C
D
E
F
G
H
Stuck? The top row is the four-link benefit chain. The bottom row is the three risk measures plus what a broken chain leaves behind.

2. Term–definition match

The definitions below are shuffled. Write the matching term from this list in the right-hand column: risk factor, screening, public health, resource allocation, relative risk, attributable risk, sensitivity, specificity, lead-time bias, overdiagnosis. 10 marks

#Definition (shuffled)Matching term
2.1The proportion of people who genuinely have the disease that a test correctly flags as positive.
2.2Detecting disease that would never have caused symptoms during that person's lifetime, then counting the person as cured.
2.3A factor linked with a higher probability of developing a disease.
2.4An estimate of how many cases in a population would be prevented if a particular exposure were removed.
2.5Testing people who have no symptoms in order to detect disease or risk early.
2.6The apparent lengthening of survival caused purely by moving the diagnosis date earlier, without the person living any longer.
2.7Deciding where funding, staff and services are most needed.
2.8The proportion of people without the disease that a test correctly clears as negative.
2.9Organised actions that protect and improve the health of a whole population.
2.10How many times more likely disease is in the exposed group than in the unexposed group.
Stuck? Revisit the cards "Putting a number on the benefit", "What makes a screening program worth running" and "When a claimed benefit is weaker than it looks".

3. True or false, with correction

Circle T or F. If the statement is false, write the corrected version on the line below. 8 marks (1 T/F + 1 correction where needed)

3.1 Finding that two variables are associated in an epidemiological study proves that one causes the other.    T  /  F

3.2 An epidemiological study can benefit public health even though it treats no individual patient.    T  /  F

3.3 A study becomes a benefit at the moment it is published.    T  /  F

3.4 If incidence of a disease falls while prevalence rises, prevention must have failed.    T  /  F

Stuck? Compare the "Common error" boxes with the card "Planning services: incidence and prevalence do different jobs".

4. Function recall

Answer each question in 1–2 sentences using precise lesson terminology. 10 marks (2 each)

4.1 What is the function of attributable risk in a public-health spending decision?

4.2 What is the function of incidence data in health-service planning, and how does it differ from prevalence?

4.3 What is the function of reporting rates separately for remote and metropolitan populations?

4.4 What is the function of specificity in judging whether a screening test is acceptable?

4.5 What is the function of the final link in the benefit chain, the outcome check?

Stuck? Revisit the cards on risk measures, screening, service planning and equity.

5. Build a concept map

Draw labelled arrows between the six terms below. Each arrow must carry a linking phrase (e.g. "identifies", "justifies", "measures", "limits"). Aim for at least 6 labelled arrows. 6 marks

Supplied terms: epidemiological study · risk factor · prevention campaign · screening program · resource allocation · equity of access.

epidemiological study
risk factor
prevention campaign
screening program
resource allocation
equity of access
Suggested chain: the study identifies a risk factor, which justifies a prevention campaign and a screening program; incidence and prevalence data from the same study guide resource allocation; equity of access limits how much benefit any of these three actually deliver.

6. Cloze, fill in the blanks

Complete the paragraph using words from the word bank below. Each word is used once. 10 marks

Word bank: populations · evidence · risk factor · prevention · screening · incidence · prevalence · attributable · equity · outcome

An epidemiological study examines patterns of disease and exposure across whole _______________. Its output is not a treatment but _______________ about how disease is distributed and which factors raise risk. Identifying a modifiable _______________ allows the health system to act through _______________ before people become ill, or through a _______________ program that detects disease early in people without symptoms. Counts matter as well as risks: _______________ shows how fast new cases are arriving, while _______________ shows how many people need ongoing care right now. Because a small increase in risk applied to a very common exposure still produces many cases, _______________ risk is the measure that usually drives budgets. Finally, a benefit reaching only some groups is a partial benefit, so _______________ must be examined, and later data must check the _______________ rather than assuming the response worked.

Stuck? Re-read the cards "Why a study can help without treating anyone" and "Four benefits to look for".
Answers, Do not peek before attempting

Q1, Labelled benefit chain

A: finding (the study identifies a pattern or risk factor). B: decision (a campaign, screening program, regulation or policy). C: implementation (the response is delivered so the target population can reach it). D: outcome check (new data test whether exposure or disease rates actually moved). E: relative risk. F: absolute risk. G: attributable risk. H: awareness (if any link breaks, the benefit shrinks to awareness only).

Q2, Term–definition matches

2.1 sensitivity · 2.2 overdiagnosis · 2.3 risk factor · 2.4 attributable risk · 2.5 screening · 2.6 lead-time bias · 2.7 resource allocation · 2.8 specificity · 2.9 public health · 2.10 relative risk.

Q3, True / false with correction

3.1 False. Correction: an association is a starting point, not proof of causation. Health authorities act when the association is strong, consistent across studies and populations, shows the exposure clearly preceding the disease, and is biologically plausible, and when confounding and bias have been considered.

3.2 True.

3.3 False. Correction: publication alone produces awareness, not benefit. Evidence becomes a benefit only when it leads to a decision that is implemented and that the target population can actually access, and when later data check the outcome.

3.4 False. Correction: falling incidence with rising prevalence usually means treatment improved, so people live longer with the disease. Incidence is the measure that judges prevention, and a falling incidence indicates prevention is working even as the number of people needing ongoing care grows.

Q4, Function recall answers

4.1 Attributable risk: It estimates the share of cases in a population that would disappear if an exposure were removed, so it identifies the largest removable portion of a disease burden. This is why a modifiable exposure with only a modest relative risk, such as physical inactivity, can still be the highest prevention priority, while a large relative risk on a rare exposure may not be.

4.2 Incidence: Incidence counts new cases arising in a period, so it shows how fast fresh demand is arriving and whether prevention is working. Prevalence counts people living with the disease at one point in time, so it sizes the ongoing care the system must fund. The two can move in opposite directions, so a planner using only one can misread demand.

4.3 Disaggregated reporting: A national average hides which groups are missing out. Reporting rates separately by region, income or Indigenous status exposes both a higher disease burden and an access barrier, which is what allows an evaluation to judge whether a benefit is equitable rather than merely large on average.

4.4 Specificity: Specificity is the proportion of healthy people the test correctly clears, so it controls the false-positive rate. Low specificity means large numbers of well people receive positive results, carrying anxiety, follow-up procedures and cost despite never having been ill, which can outweigh the benefit of the cases the test finds.

4.5 Outcome check: Later data test whether exposure, behaviour or disease rates actually changed after the response was implemented. Without it a benefit is asserted rather than evaluated, and the study cannot be said to have delivered more than awareness.

Q5, Sample concept map

Correct maps should include arrows such as:

  • epidemiological study identifies a modifiablerisk factor
  • risk factor justifies targeting it with aprevention campaign
  • risk factor identifies who should be offered ascreening program
  • epidemiological study supplies incidence and prevalence data that guideresource allocation
  • equity of access limits the real benefit delivered by aprevention campaign (or screening program)
  • screening program generates data that feed back into a furtherepidemiological study

Award 1 mark per correct labelled arrow (maximum 6). Do not award a mark for an arrow implying the study directly treats patients.

Q6, Cloze answers (in order)

populations · evidence · risk factor · prevention · screening · incidence · prevalence · attributable · equity · outcome